Biotech company Ginkgo Bioworks announced a collaboration with Pfizer, worth up to $331 million, focused on discovering new RNA-based drug candidates.
Read the full post on Becker's Hospital Review - Healthcare News
Pfizer, Ginkgo ink $331M partnership
